Emerging Issues on HPV Infections: From Science to Practice
Karger, 2006 - Medical - 275 pages
Despite the substantial efforts made to prevent the disease by early detection, cervical cancer remains a leading cause of mortality among women worldwide. The European Research Organization on Genital Infection and Neoplasia (EUROGIN) pursues a wide variety of educational and training activities, aiming to spread accurate and state-of-the-art information in the field of cervical cancer prevention. The latest outcome of these activities is presented in this book. Providing a concise update of the current knowledge on human papillomavirus (HPV) infections and their intimate link to cervical cancer, the book focuses on five interrelated topics: high- and low-risk HPV infections, methods for HPV detection and use of molecular markers, HPV testing in primary screening and patient management, morphological diagnosis and treatment, as well as prevention of cervical cancer by vaccines. Written by leading international experts, this publication is targeted at a multidisciplinary readership consisting of health care professionals from diverse specialties engaged in the management of HPV-associated diseases.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Epidemiology of Oncogenic and Nononcogenic HPV Types and
Immune Responses to Genital
Bridging the Communication Gap between Practitioners
14 other sections not shown
Other editions - View all
16 and HPV abnormal antibodies ASC-H ASC-US ASCUS assay associated Biomarkers biopsy Bosch FX carcinoma cervical cancer screening cervical cytology cervical intraepithelial neoplasia cervical neoplasia cervical screening CIN1 CIN2 CIN3 Clin clinical cohort colposcopy cost-effective cytology detection diagnosis disease dysplasia efficacy epithelium evaluation expression follow-up gene genital genital warts genome high-risk HPV HPV DNA testing HPV infection HPV testing HPV types HPV vaccination HPV-positive HPV6 HR infections HR-HPV HSIL human papillomavirus human papillomavirus infection human papillomavirus type immune impact incidence Int J Cancer invasive cervical cancer low-grade LSIL management of women markers Meijer CJ Monsonego Natl Cancer Inst Obstet Gynecol oncogenic Pap smear Pap test partners Pathol patients persistent pl6INK4a potential PreTect HPV-Proofer prevalence prevent primary screening protection protein risk samples screening programs sensitivity sexual specificity squamous intraepithelial lesions studies telomerase ThinPrep tion triage trial viral virus virus-like particle Wright TC